Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Although many health experts around the world must stay focused on the ongoing viral pandemic caused by SARS-CoV-2, similar viruses and microbial organisms such as bacteria could create the next global killer. Experts discuss the most likely culprits.
The pandemic has been a source of a sometimes overwhelming sense of uncertainty. We asked our readers to share how they have used art to document their experiences.
There has been a lot of hype around the applications of machine learning in medicine. But how is machine learning actually helping bench-to-bedside scientists and clinicians do their jobs?
Goodbye 2020, a year of arguably too many challenges for the world. As tempting as it is to leave this year behind, the biomedical community is forever changed by the pandemic, while business as usual needs to carry on. Looking forward to a new year, experts share six trends for the biomedical community in 2021.
As the US general election looms, feelings are more than mixed about science policy for biomedical and medical research under US President Donald Trump’s administration.
In recent years, patient research groups have spurred culture shifts in biomedical research and governance, with many health experts lauding the benefit of these groups’ being embedded in the research process. Some, however, question private-sector influence in these groups’ newfound power.
Patients with rare diseases, and the scientists who study those diseases, were long inhibited by geographic sparsity. But the social-media age has made it much easier for them to band together to leverage their experience and push forward change.
Only 6 months after the first identification of the causative coronavirus, vaccine candidates against COVID-19 are already in clinical trials. The secret weapon behind the speed of development? Computational immunology.
Scientists have been investigating a plethora of drugs that may be repurposed to fight COVID-19. The hope is that of the 15 drugs listed here, some could be discovered as a treatment for this disease.
A seasoned public-health institute puts Nigeria in a good position to respond to COVID-19, although there are area-specific challenges to be addressed. Nature Medicine reports from Nigeria.
Some say Parkinson’s disease (PD) could start in the gut. Most agree that this organ could potentially offer avenues for the diagnosis, prevention and management of PD.
Once agents of the anti-establishment, psychedelics are now moving to the commercial market, with regulatory approvals and phase 3 trials opening the door to mainstream therapeutics.